SCHEMBL23966809

SCHEMBL23966809

C[SH](C)(C)(C)CCOCn1c(CO)nc2cc(OCC3CC3)c(C#N)cc21

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IKBKE Q14164 5/20 0.38
TBK1 Q9UHD2 4/20 0.38
XDH P47989 6/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909013 0.88 XDH (0.38) IKBKETBK1XDH
SCHEMBL23966834 0.88 XDH (0.38) IKBKETBK1XDH
SCHEMBL23915306 0.85 XDH (0.36) IKBKETBK1XDH
SCHEMBL23909001 0.84 XDH (0.38) IKBKETBK1XDH
SCHEMBL23915309 0.83 XDH (0.37) IKBKETBK1XDH
SCHEMBL23909131 0.80 XDH (0.36) IKBKETBK1XDH
SCHEMBL23914584 0.78 XDH (0.34) IKBKETBK1XDH
SCHEMBL23914757 0.77 XDH (0.36) IKBKETBK1XDH
SCHEMBL23914583 0.76 XDH (0.35) IKBKETBK1XDH
SCHEMBL23966550 0.76 CNR2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed